FDA establishment 1000113778, Tampa, Florida, United States. Part of Bausch & Lomb's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations, its recalls since 2016, and the shipments FDA refused at the border.
FY2018 to FY2027 to date; 2 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
Inspections citing each reference
| Mar 20, 2026 | Drugs · Drug Quality Assurance | None posted | Official Action Indicated (OAI) |
| Aug 25, 2023 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Jan 30, 2019 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Aug 10, 2018 | Drugs · Drug Quality Assurance | 5 cited references
| Official Action Indicated (OAI) |
| May 26, 2017 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Feb 25, 2016 | Drugs · Unapproved and Misbranded DrugsDrugs · Postmarket Surv. and Epidemiology; Drugs · Drug Quality Assurance | None posted | Official Action Indicated (OAI) |
| Mar 6, 2015 | Drugs · Unapproved and Misbranded DrugsDevices · Postmarket Assurance: Devices; Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Jul 12, 2013 | Drugs · Unapproved and Misbranded DrugsDrugs · Drug Quality Assurance | 1 cited reference
| Voluntary Action Indicated (VAI) |
| Mar 21, 2012 | Drugs · Bioresearch MonitoringDrugs · Drug Quality Assurance | 1 cited reference
| No Action Indicated (NAI) |
| Oct 25, 2010 | Drugs · Drug Quality AssuranceDevices · Compliance: Devices | None posted | Voluntary Action Indicated (VAI) |
| Oct 30, 2009 | Devices · Compliance: DevicesDrugs · Drug Quality Assurance; Drugs · Postmarket Surv. and Epidemiology | None posted | No Action Indicated (NAI) |
| Lotemax (loteprednol etabonate ophthalmic gel 0.5%), Sterile, Rx Only, 5 g box, Bausch & Lomb, a division of…Drug · D-1396-2019 | Class III | Jun 17, 2019 |
| NasalCrom (cromolyn sodium) Nasal Spray, USP, 5.2 mg per spray, 200 metered sprays, 0.88 FL OZ (26 mL)…Drug · D-0899-2017 | Class II | Jun 6, 2017 |
| Cyclopentolate Hydrochloride Ophthalmic Solution USP, 1%, Packaged in a) 2 mL Bottles (NDC: 24208-735-01)…Drug · D-0645-2016 · 3 products | Class III | Jan 18, 2016 |
| Product | Charges | Latest |
|---|---|---|
| WATER, PURIFIED (EYEWASH)Drugs · 65FAK06 | Dec 22, 2025 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. FDA Data Dashboard, warning letters and enforcement reports